Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
999 999.9999
KRW
Market Closed
Market Cap:
₩82.3T
Balance Sheet
Balance Sheet Decomposition
Samsung Biologics Co Ltd
Samsung Biologics Co Ltd
Balance Sheet Decomposition is not available for
Samsung Biologics Co Ltd
Samsung Biologics Co Ltd
Balance Sheet
Samsung Biologics Co Ltd
Samsung Biologics Co Ltd
Currency: KRW
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
104 400
|
96 287
|
34 510
|
230 338
|
358 088
|
17 622
|
125 101
|
28 850
|
47 410
|
890 820
|
367 937
|
391 222
|
148 851
|
|
| Cash Equivalents |
104 400
|
96 287
|
34 510
|
230 338
|
358 088
|
17 622
|
125 101
|
28 850
|
47 410
|
890 820
|
367 937
|
391 222
|
148 851
|
|
| Short-Term Investments |
0
|
0
|
0
|
970 000
|
0
|
1 090 081
|
530 040
|
800 046
|
1 300 040
|
2 280 885
|
1 654 513
|
907 350
|
1 307 175
|
|
| Total Receivables |
6 324
|
28 694
|
37 009
|
75 631
|
25 817
|
141 833
|
207 930
|
246 197
|
430 242
|
820 156
|
742 712
|
1 246 732
|
780 094
|
|
| Accounts Receivables |
178
|
15 266
|
35 031
|
69 609
|
19 355
|
135 951
|
205 873
|
245 797
|
430 242
|
820 156
|
742 712
|
1 246 732
|
780 094
|
|
| Other Receivables |
6 146
|
13 428
|
1 978
|
6 022
|
6 462
|
5 881
|
2 057
|
400
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
39 708
|
74 402
|
119 177
|
164 220
|
209 987
|
302 361
|
452 470
|
645 960
|
1 012 871
|
2 375 819
|
2 641 368
|
2 818 276
|
2 128 164
|
|
| Other Current Assets |
5 964
|
17 455
|
2 157
|
21 237
|
27 103
|
25 788
|
40 720
|
30 293
|
32 613
|
89 977
|
115 457
|
154 538
|
44 082
|
|
| Total Current Assets |
156 395
|
216 838
|
192 854
|
1 461 425
|
620 995
|
1 577 684
|
1 356 262
|
1 751 347
|
2 823 175
|
6 457 657
|
5 521 988
|
5 518 118
|
4 408 367
|
|
| PP&E Net |
377 647
|
761 294
|
890 256
|
1 090 960
|
1 513 333
|
1 717 721
|
1 718 911
|
1 760 728
|
2 227 687
|
3 871 452
|
4 342 424
|
5 837 482
|
6 037 532
|
|
| PP&E Gross |
377 647
|
761 294
|
890 256
|
1 090 960
|
1 513 333
|
1 717 721
|
1 718 911
|
1 760 728
|
2 227 687
|
3 871 452
|
4 342 424
|
5 837 482
|
6 037 532
|
|
| Accumulated Depreciation |
12 890
|
36 257
|
51 490
|
107 274
|
171 109
|
256 228
|
376 961
|
506 623
|
647 011
|
817 873
|
1 057 354
|
1 330 143
|
1 626 432
|
|
| Intangible Assets |
116 673
|
312 219
|
14 286
|
14 045
|
18 999
|
19 982
|
21 828
|
23 345
|
32 172
|
4 283 699
|
4 154 480
|
3 887 695
|
60 193
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 677 608
|
1 677 608
|
1 677 608
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
77 079
|
131 071
|
197 863
|
193 759
|
188 262
|
254 469
|
309 936
|
308 003
|
|
| Long-Term Investments |
0
|
53 922
|
4 837 539
|
4 944 356
|
5 008 234
|
2 561 803
|
2 673 493
|
2 654 676
|
2 661 309
|
30 775
|
40 096
|
59 220
|
78 098
|
|
| Other Long-Term Assets |
8 846
|
11 425
|
25 559
|
22 230
|
21 530
|
26 140
|
10 063
|
36 242
|
31 907
|
72 598
|
55 133
|
46 238
|
168 549
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 677 608
|
1 677 608
|
1 677 608
|
0
|
|
| Total Assets |
659 561
N/A
|
1 355 698
+106%
|
5 960 494
+340%
|
7 533 016
+26%
|
7 183 091
-5%
|
5 980 409
-17%
|
5 911 627
-1%
|
6 424 201
+9%
|
7 970 011
+24%
|
16 582 050
+108%
|
16 046 197
-3%
|
17 336 296
+8%
|
11 060 742
-36%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
2 638
|
957
|
358
|
1 521
|
14 479
|
3 811
|
12 290
|
54 984
|
32 251
|
59 616
|
208 278
|
726 420
|
73 630
|
|
| Accrued Liabilities |
42 502
|
62 005
|
28 341
|
23 046
|
28 670
|
49 777
|
43 876
|
64 356
|
74 322
|
207 437
|
281 317
|
545 403
|
314 573
|
|
| Short-Term Debt |
52 009
|
48 526
|
10 109
|
0
|
40 000
|
90 000
|
150 000
|
30 000
|
50 000
|
582 783
|
654 500
|
207 000
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
403 694
|
98 677
|
296 583
|
254 899
|
167 440
|
117 392
|
698 264
|
877 436
|
258 594
|
326 971
|
|
| Other Current Liabilities |
72 080
|
125 306
|
1 872 861
|
2 048 284
|
2 105 616
|
270 359
|
229 440
|
272 521
|
833 330
|
2 633 441
|
2 136 331
|
2 115 771
|
1 817 743
|
|
| Total Current Liabilities |
169 230
|
236 794
|
1 911 669
|
2 476 545
|
2 287 442
|
710 530
|
690 505
|
589 301
|
1 107 295
|
4 181 542
|
4 157 861
|
3 853 188
|
2 532 917
|
|
| Long-Term Debt |
71 000
|
427 199
|
681 792
|
439 363
|
407 236
|
486 113
|
248 808
|
587 465
|
1 125 355
|
1 232 986
|
377 397
|
1 020 645
|
600 124
|
|
| Deferred Income Tax |
0
|
0
|
581 574
|
526 671
|
505 316
|
534 542
|
470 545
|
449 847
|
487 712
|
1 214 216
|
1 184 420
|
972 062
|
0
|
|
| Minority Interest |
29 406
|
32 592
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
200
|
207
|
0
|
|
| Other Liabilities |
34 868
|
60 973
|
10 624
|
8 058
|
6 647
|
93 755
|
147 315
|
198 804
|
258 547
|
968 833
|
495 827
|
585 518
|
476 590
|
|
| Total Liabilities |
304 504
N/A
|
757 558
+149%
|
3 185 660
+321%
|
3 450 637
+8%
|
3 206 640
-7%
|
1 824 940
-43%
|
1 557 173
-15%
|
1 825 418
+17%
|
2 978 909
+63%
|
7 597 576
+155%
|
6 215 705
-18%
|
6 431 620
+3%
|
3 609 631
-44%
|
|
| Equity | ||||||||||||||
| Common Stock |
59 435
|
101 833
|
137 844
|
165 413
|
165 413
|
165 413
|
165 413
|
165 413
|
165 413
|
177 935
|
177 935
|
177 935
|
115 727
|
|
| Retained Earnings |
218 755
|
314 664
|
1 601 530
|
1 424 707
|
1 327 735
|
1 509 719
|
1 712 623
|
1 953 598
|
2 347 187
|
3 145 601
|
4 003 293
|
5 086 609
|
6 870 961
|
|
| Additional Paid In Capital |
516 719
|
808 874
|
1 039 891
|
2 496 583
|
2 496 583
|
2 496 583
|
2 496 583
|
2 496 627
|
2 496 627
|
6 523 004
|
6 523 004
|
6 523 004
|
4 242 505
|
|
| Unrealized Security Profit/Loss |
0
|
15 229
|
9 664
|
11 368
|
4 601
|
5 564
|
5 433
|
3 695
|
4 177
|
4 992
|
0
|
0
|
0
|
|
| Other Equity |
2 342
|
13 132
|
14 095
|
15 691
|
17 880
|
21 811
|
25 598
|
20 549
|
22 302
|
867 058
|
873 739
|
882 872
|
3 778 082
|
|
| Total Equity |
355 058
N/A
|
598 140
+68%
|
2 774 834
+364%
|
4 082 379
+47%
|
3 976 451
-3%
|
4 155 468
+5%
|
4 354 454
+5%
|
4 598 783
+6%
|
4 991 102
+9%
|
8 984 474
+80%
|
9 830 492
+9%
|
10 904 676
+11%
|
7 451 111
-32%
|
|
| Total Liabilities & Equity |
659 561
N/A
|
1 355 698
+106%
|
5 960 494
+340%
|
7 533 016
+26%
|
7 183 091
-5%
|
5 980 409
-17%
|
5 911 627
-1%
|
6 424 201
+9%
|
7 970 011
+24%
|
16 582 050
+108%
|
16 046 197
-3%
|
17 336 296
+8%
|
11 060 742
-36%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
36
|
36
|
36
|
44
|
44
|
44
|
44
|
44
|
44
|
46
|
46
|
46
|
46
|
|
Switch to:
Switch to:
See Also
Discover More
